Biotage® Oligo SPE is a solid-phase extraction (SPE) solution specifically developed for efficient extraction of oligonucleotide-based therapeutics from biological samples, including plasma, serum, urine and tissue homogenates. Using mixed-mode weak anion exchange (WAX) chemistry, Biotage® Oligo SPE effectively removes interfering proteins, salts, sugars, lipids and DNA fragments. Its tailored sorbent design delivers clean extracts and consistently high recoveries across a variety of oligonucleotide structures and chemistries.
• Accurately quantify a wide range of therapeutic oligonucleotides, even at low concentrations
• Effectively removes matrix interferences to deliver cleaner extracts for consistent, high-sensitivity LC-MS/MS analysis.
• Supports robust, high-throughput workflow with seamless integration into automated systems.
• Expert-developed protocols streamline method development and optimization, minimizing oligonucleotide degradation and maximizing analyte recovery from protein binding.
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
654-0010-PX01 | Biotage® Oligo SPE 10 mg plate | 1 | 423 USD | Add to quote/cart |
654-0001-AXG | Biotage® Oligo SPE 10 mg/1 mL (Tabless) | 100 | 817 USD | Add to quote/cart |
654-0002-LVP | Biotage® Oligo SPE 2 mg µ elution plate | 1 | 464 USD | Add to quote/cart |
654-0030-PX01 | Biotage® Oligo SPE 30 mg plate | 1 | 486 USD | Add to quote/cart |
654-0003-AXG | Biotage® Oligo SPE 30 mg/1 mL (Tabless) | 100 | 840 USD | Add to quote/cart |
654-0080-PX01 | Biotage® Oligo SPE 80 mg plate | 1 | 531 USD | Add to quote/cart |
654-0008-AXG | Biotage® Oligo SPE 80 mg/1 mL (Tabless) | 100 | 869 USD | Add to quote/cart |
654-0008-BXG | Biotage® Oligo SPE 80 mg/3 mL (Tabless) | 50 | 440 USD | Add to quote/cart |
121-5203 | Collection Plate, 2 mL Square | 50 | 381 USD | Add to quote/cart |
121-5204 | Pierceable Sealing Cap | 50 | 259 USD | Add to quote/cart |
Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Copyright © 2025 Biotage